Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Clinical Medicine, The Arctic University of Norway, Tromsø, Norway.
Nat Commun. 2021 Sep 22;12(1):5596. doi: 10.1038/s41467-021-25888-7.
Contact activation refers to the process of surface-induced activation of factor XII (FXII), which initiates blood coagulation and is captured by the activated partial thromboplastin time (aPTT) assay. Here, we show the mechanism and diagnostic implications of FXII contact activation. Screening of recombinant FXII mutants identified a continuous stretch of residues Gln317-Ser339 that was essential for FXII surface binding and activation, thrombin generation and coagulation. Peptides spanning these 23 residues competed with surface-induced FXII activation. Although FXII mutants lacking residues Gln317-Ser339 were susceptible to activation by plasmin and plasma kallikrein, they were ineffective in supporting arterial and venous thrombus formation in mice. Antibodies raised against the Gln317-Ser339 region induced FXII activation and triggered controllable contact activation in solution leading to thrombin generation by the intrinsic pathway of coagulation. The antibody-activated aPTT allows for standardization of particulate aPTT reagents and for sensitive monitoring of coagulation factors VIII, IX, XI.
接触激活是指表面诱导的因子 XII(FXII)活化过程,它启动血液凝固,并被活化部分凝血活酶时间(aPTT)测定法捕获。在这里,我们展示了 FXII 接触激活的机制和诊断意义。对重组 FXII 突变体的筛选确定了一个连续的残基 Gln317-Ser339 区域,该区域对于 FXII 表面结合和激活、凝血酶生成和凝血至关重要。跨越这些 23 个残基的肽与表面诱导的 FXII 激活竞争。尽管缺乏残基 Gln317-Ser339 的 FXII 突变体容易被纤溶酶和血浆激肽释放酶激活,但它们在支持小鼠动脉和静脉血栓形成方面无效。针对 Gln317-Ser339 区域的抗体诱导 FXII 活化,并在溶液中引发可控的接触激活,导致凝血的内在途径生成凝血酶。抗体激活的 aPTT 可实现颗粒 aPTT 试剂的标准化,并灵敏监测凝血因子 VIII、IX、XI。
J Thromb Haemost. 2018-12-10
J Thromb Haemost. 2013-7
Arterioscler Thromb Vasc Biol. 2018-8
Arterioscler Thromb Vasc Biol. 2014-5-22
Res Pract Thromb Haemost. 2025-7-16
Acta Crystallogr D Struct Biol. 2025-7-1
J Thromb Thrombolysis. 2025-4-26
Int J Implant Dent. 2023-11-17
Semin Thromb Hemost. 2024-10
Thromb Haemost. 2020-1-15
Front Immunol. 2019-8-22
Circ Res. 2019-2